Department of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta and Alberta Health Services, Edmonton, AB, Canada.
Critical Care Strategic Clinical Network, Alberta Health Services, Alberta, Canada.
Can J Public Health. 2023 Aug;114(4):547-554. doi: 10.17269/s41997-023-00777-2. Epub 2023 May 10.
The coronavirus disease 2019 (COVID-19) pandemic has precipitated a prolonged public health crisis. Numerous public health protections were widely implemented. The availability of effective and safe vaccines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presented an opportunity to resolve this crisis; however, vaccine uptake was slow and inconsistent. This study evaluated the potential for preventable hospitalizations and avoidable resource use among eligible non-vaccinated persons hospitalized for COVID-19 had these persons been vaccinated.
This was a retrospective, population-based cohort study. The population-at-risk were persons aged ≥ 12 years in Alberta (mid-year 2021 population ~ 4.4 million). The primary exposure was vaccination status. The primary outcome was hospitalization with confirmed SARS-CoV-2, and secondary outcomes included avoidable hospitalizations, avoidable hospital bed-days, and the potential cost avoidance related to COVID-19. The study inception period was 27 September 2021 to 25 January 2022. Data on COVID-19 hospitalizations, vaccination status, health services, and costs were obtained from the Government of Alberta and from the Discharge Abstract Database.
Hospitalizations occurred in 3835, 1907, and 481 persons who were non-vaccinated, fully vaccinated, and boosted (risk of hospitalization/100,000 population: 886, 92, and 43), respectively. For non-vaccinated persons compared with fully vaccinated and boosted persons, the risk ratios (95%CI) of hospitalization were 9.7 (7.9-11.8) and 20.6 (17.9-23.6), respectively. For non-vaccinated persons, estimates of avoidable hospitalizations and bed-days used were 3439 and 36,331 if fully vaccinated and 3764 and 40,185 if boosted. Estimates of cost avoidance for non-vaccinated persons were $101.46 million if fully vaccinated and $110.24 million if boosted.
Eligible non-vaccinated persons with COVID-19 had tenfold and 21-fold higher risks of hospitalization relative to whether they had been fully vaccinated or boosted, resulting in considerable avoidable hospital bed-days and costs.
2019 年冠状病毒病(COVID-19)大流行引发了一场长期的公共卫生危机。广泛实施了许多公共卫生保护措施。严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)有效且安全的疫苗的出现为解决这场危机提供了机会;然而,疫苗接种率缓慢且不一致。本研究评估了在 COVID-19 住院的符合条件的未接种疫苗者中,如果这些人接种了疫苗,是否可以避免住院和避免资源使用。
这是一项回顾性、基于人群的队列研究。高危人群为艾伯塔省年龄≥12 岁的人群(2021 年年中人口约为 440 万)。主要暴露因素为疫苗接种状况。主要结局是因 COVID-19 住院且确诊为 SARS-CoV-2,次要结局包括可避免的住院、可避免的住院天数以及与 COVID-19 相关的潜在成本避免。研究开始时间为 2021 年 9 月 27 日至 2022 年 1 月 25 日。COVID-19 住院、疫苗接种状况、卫生服务和费用数据来自艾伯塔省政府和出院摘要数据库。
未接种疫苗、完全接种疫苗和加强接种疫苗的人群住院人数分别为 3835 例、1907 例和 481 例(每 100,000 人口的住院风险分别为 886、92 和 43)。与完全接种疫苗和加强接种疫苗的人相比,未接种疫苗的人住院的风险比(95%CI)分别为 9.7(7.9-11.8)和 20.6(17.9-23.6)。对于未接种疫苗的人,如果完全接种疫苗,估计可避免的住院和住院天数分别为 3439 和 36,331,如果加强接种疫苗,估计可避免的住院和住院天数分别为 3764 和 40,185。如果完全接种疫苗,未接种疫苗者的成本避免估计为 1.0146 亿美元,如果加强接种疫苗,成本避免估计为 1.1024 亿美元。
符合条件的 COVID-19 未接种疫苗者的住院风险是完全接种疫苗或加强接种疫苗者的 10 倍和 21 倍,导致大量可避免的住院床位和费用。